Pharvaris (PHVS) Change in Accured Expenses (2020 - 2026)

Pharvaris has reported Change in Accured Expenses for 7 years, with the latest figure at -$5.1 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 812.72% year-over-year to -$5.1 million; the trailing twelve-month figure through Mar 2026 stood at -$35.0 billion (up 55.59% YoY), and the FY2024 full-year result was $4.8 million, up 733.84% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$5.1 million, up from -$1101.9 billion in the prior quarter.
• The five-year high for Change in Accured Expenses was $3974.7 billion in Q2 2024, with the low at -$4053.4 billion in Q3 2024.
• Historically, Change in Accured Expenses has averaged -$7.1 billion across 5 years, with a median of $955329.1 in 2022.
• The largest YoY upside for Change in Accured Expenses was 86970295.74% in 2023 against a maximum downside of 36593338.77% in 2023.
• Pharvaris' Change in Accured Expenses stood at $894776.3 in 2022, then sank by 212.17% to -$1.0 million in 2023, then jumped by 607.72% to $5.1 million in 2024, then sank by 21623930.5% to -$1101.9 billion in 2025, then soared by 100.0% to -$5.1 million in 2026.
• The last three Change in Accured Expenses figures came in at -$5.1 million (Q1 2026), -$1101.9 billion (Q3 2025), and $1067.0 billion (Q2 2025), per Business Quant data.